PMID: 9187257Jun 1, 1997Paper

Cloning and functional expression of a human liver organic cation transporter

Molecular Pharmacology
L ZhangK M Giacomini

Abstract

Polyspecific organic cation transporters in the liver mediate the elimination of a wide array of endogenous amines and xenobiotics. In contrast to our understanding of the mechanisms of organic cation transport in rat liver, little is known about the mechanisms of organic cation transport in the human liver. We report the cloning, sequencing, and functional characterization of the first human polyspecific organic cation transporter from liver (hOCT1). hOCT1 (554 amino acids) is 78% identical to the previously cloned organic cation transporter from rat, rOCT1 [Nature (Lond.) 372:549-552 (1994)]. In Xenopus laevis oocytes injected with the cRNA of hOCT1, the specific uptake of the organic cation 3H-1-methyl-4-phenylpyridinium (3H-MPP+) was significantly enhanced (8-fold) over that in water-injected oocytes. Uptake of 3H-MPP+ was saturable (K(m) = 14.6 +/- 4.39 microM) and sensitive to membrane potential. Both small monovalent organic cations such as tetraethylammonium and N1-methylnicotinamide and bulkier organic cations (e.g., vecuronium and decynium-22) inhibited the uptake of 3H-MPP+. In addition, the bile acid taurocholate inhibited the uptake of 3H-MPP+ in oocytes expressing hOCT1. Northern analysis demonstrated that the mRN...Continue Reading

References

Oct 6, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·K Turnheim, F Lauterbach
Feb 15, 1978·Biochemical Pharmacology·R J VonkM J Hardonk
Aug 1, 1992·Current Opinion in Cell Biology·J K GriffithP J Henderson
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M A FrohmanG R Martin
Feb 1, 1989·The Journal of Cell Biology·M Kozak
Aug 1, 1987·British Journal of Anaesthesia·P G WaserE Kaiser-Schönenberger
May 5, 1982·Journal of Molecular Biology·J Kyte, R F Doolittle
Jun 1, 1994·Pflügers Archiv : European journal of physiology·K M GiacominiH Murer
Jul 17, 1995·Biochimica Et Biophysica Acta·R P Oude ElferinkG M Groothuis
Oct 1, 1993·Physiological Reviews·J B Pritchard, D S Miller
Jul 16, 1996·Biochemical and Biophysical Research Communications·M OkudaK Inui
Oct 1, 1996·Mammalian Genome : Official Journal of the International Mammalian Genome Society·N Schweifer, D P Barlow
Aug 1, 1996·Naunyn-Schmiedeberg's Archives of Pharmacology·F MartelE Schömig
Dec 20, 1996·The Journal of Biological Chemistry·A E BuschH Koepsell

❮ Previous
Next ❯

Citations

Oct 17, 1998·British Journal of Pharmacology·T BreidertE Schömig
Feb 3, 1999·Molecular Pharmacology·J Wang, K M Giacomini
Apr 27, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R M GreenD R Beier
Dec 22, 1999·The American Journal of Physiology·D H Sweet, J B Pritchard
Aug 15, 2001·American Journal of Physiology. Cell Physiology·P K DudejaH M Said
Aug 15, 2001·American Journal of Physiology. Renal Physiology·P ArndtH Koepsell
Jan 31, 2002·World Journal of Gastroenterology : WJG·C StancaG A Kullak-Ublick
Dec 20, 2002·The Journal of Pharmacology and Experimental Therapeutics·Rommel G TironaRichard B Kim
Dec 25, 2004·Drug Metabolism and Pharmacokinetics·Ayako TakeuchiKen-Ichi Inui
Aug 15, 2006·Archives of Pharmacal Research·Moon Kyoung Kim, Chang-Koo Shim
Jan 16, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ho-Jin KangJae-Gook Shin
Mar 1, 2008·Nature Reviews. Drug Discovery·Paul D Dobson, Douglas B Kell
Apr 4, 2008·Pharmacogenomics·Hiroshi TakaneIchiro Ieiri
May 20, 2008·Expert Opinion on Drug Metabolism & Toxicology·Michael A PacanowskiChristina L Aquilante
Oct 31, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xin MingDhiren R Thakker
Aug 1, 2008·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·G Ciarimboli
Jun 2, 2009·Biological & Pharmaceutical Bulletin·Paranee MeetamVaranuj Chatsudthipong
Jul 11, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anne T NiesElke Schaeffeler
Jan 16, 2015·Cell Cycle·Ligong ChenKathleen M Giacomini
Apr 16, 2016·Therapeutic Drug Monitoring·Maja MaticKarel Allegaert
Jul 8, 2016·Journal of Clinical Pharmacology·Mitesh PatelMaciej J Zamek-Gliszczynski
Nov 5, 2019·American Journal of Physiology. Renal Physiology·Stephen H Wright
Oct 3, 1999·Cell Biochemistry and Biophysics·D H Sweet, J B Pritchard
Sep 13, 2001·The Journal of Biological Chemistry·D H SweetJ B Pritchard
Jul 12, 2001·The Journal of Biological Chemistry·G PietigE Schlatter
Sep 21, 2000·American Journal of Physiology. Renal Physiology·U KarbachH Koepsell
Nov 14, 2002·American Journal of Physiology. Renal Physiology·Birgitta C BurckhardtGerhard Burckhardt
Jun 13, 2002·American Journal of Physiology. Renal Physiology·Xiaohong ZhangStephen H Wright
Jun 4, 1999·Journal of Gastroenterology and Hepatology·T KamisakoY Adachi
Jul 19, 2003·Pharmacological Reviews·Naomi MizunoYuichi Sugiyama
Dec 25, 2004·Drug Metabolism and Pharmacokinetics·Naomi Mizuno, Yuichi Sugiyama

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.